Former CVS CFO joins Dollar General’s board of directors
GOODLETTSVILLE, Tenn. Former CVS Caremark CFO David Rickard has been appointed to Dollar General’s board of directors. He also will serve as chair of the company’s audit committee.
Rickard served as EVP, CFO and chief administrative officer of CVS Caremark from September 1999 until December 2009. Prior to joining CVS Caremark, he was the SVP and CFO of RJR Nabisco Holdings Corp. from 1997 to 1999. He has been a director of Harris Corp. since October 2001, and Jones Lang LaSalle Inc. since July 2007.
“We are pleased to welcome such a retail veteran to our board,” stated Rick Dreiling, Dollar General’s chairman and CEO. “Dave’s years of experience and diverse retail industry background will be an asset to the Dollar General board. We are certain that his expertise will serve Dollar General well as we work to move the company forward.”
Dreiling is a retail pharmacy veteran himself. Prior to joining Dollar General in January 2008 as CEO, he had been chairman and CEO of Duane Reade. Before that, Dreiling served as EVP and COO of Longs Drug Stores, starting there in 2003. Prior to that, he was EVP marketing, manufacturing and distribution for grocery chain Safeway.
Adherence to HIV therapy may cut healthcare costs, study finds
NEW YORK Increased adherence of HIV therapy may be cost-effective, according to a new study.
Researchers studied 6,833 HIV-infected adults in a South African HIV cohort who started antiretroviral therapy between Aug. 6, 2000, and April 20, 2006. The purpose of the study was to determine the effect of antiretroviral therapy adherence on direct healthcare costs among adults in a resource-limited setting.
The study, led by Jean Nachega, M.D., Harvard School of Public Health, and colleagues found high antiretroviral therapy adherence was associated with lower mean monthly direct healthcare costs, particularly reduced hospitalization costs. Although medication costs were higher for patients who took their drugs as prescribed, overall average monthly costs for those with the best adherence were $63 a month lower than for those with the worst adherence rates.
The findings were published in the Jan. 5 issue of Annals of Internal Medicine.
My Girl’s radiation cream now available at oncology boutiques, all-natural stores and pharmacies
BOSTON Breast cancer patients looking for a natural burn cream to protect their skin from the effects of radiation therapy can now purchase My Girl’s radiation cream in eight states.
The cream now is available in oncology boutiques, all-natural stores and pharmacies in Connecticut, Massachusetts, New York, Maine, Florida, Georgia, Virginia and West Virginia.
The calendula-based burn cream reduces pain and itching and decreases inflammation that may occur as a result of radiation therapy.
My Girl’s radiation cream has won praise from cancer patients undergoing radiation therapy as it fills a void for those seeking a non-greasy, hypoallergenic burn cream that contains no alcohol, fragrance, artificial preservatives, toxic chemicals, mineral oil, petroleum or parabens.
For more information, visit http://www.radiationcream.com.